The Centers for Medicare and Medicaid Services (CMS) quietly announced it negotiated down 2027 prices for 15 drugs following negotiations between the agency and individual drugmakers.
The announcement concludes three rounds of direct negotiations between CMS and the drugmakers and represents the second annual cycle of negotiations conducted through the Medicare Drug